Report cover image

Global Pregabalin Market Growth 2025-2031

Published Oct 15, 2025
Length 159 Pages
SKU # LPI20471580

Description

The global Pregabalin market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031.

The impact of the latest U.S. tariff measures and the corresponding policy responses from countries worldwide on market competitiveness, regional economic performance, and supply chain configurations will be comprehensively evaluated in this report.

Pregabalin is an anticonvulsant drug used for the treatment of epilepsy, neuropathic pain, fibromyalgia, and generalized anxiety disorder. Its mode of action involves decrease in pain signals sent by the damaged nerves in the body.

Increase in geriatric population suffering from neuropathic diabetes and rise in prevalence of diabetes, HIV, cancer, epilepsy, fibromyalgia, and other such disorders are expected to drive the Pregabalin market.

LP Information, Inc. (LPI) ' newest research report, the “Pregabalin Industry Forecast” looks at past sales and reviews total world Pregabalin sales in 2024, providing a comprehensive analysis by region and market sector of projected Pregabalin sales for 2025 through 2031. With Pregabalin sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Pregabalin industry.

This Insight Report provides a comprehensive analysis of the global Pregabalin landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Pregabalin portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Pregabalin market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Pregabalin and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Pregabalin.

This report presents a comprehensive overview, market shares, and growth opportunities of Pregabalin market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:
Tablet
Capsule
Oral Solution

Segmentation by Application:
Hospitals
Clinics
Others

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
ZCL Chemicals
Olon S.p.A.
AASraw Biochemical Technology
Changzhou Pharmaceutical Factory (CPF)
Almelo Pvt. Ltd.
Divi’s Laboratories
Angels Pharma
ARITE Pharmaceutical
BAL Pharma
Bazayan
Aurobindo Pharma
Hikal
Glenmark Life Sciences
Dongbang FTL
Teva Pharmaceutical Industries
Divi’s Laboratories
Chemo Iberica
Maps Laboratories
Laurus Labs
Zhejiang Huahai Pharmaceutical
Vasudha Pharma Chem
Sun Pharmaceutical Industries
CTX Life Sciences
Srini Pharmaceuticals

Key Questions Addressed in this Report

What is the 10-year outlook for the global Pregabalin market?

What factors are driving Pregabalin market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Pregabalin market opportunities vary by end market size?

How does Pregabalin break out by Type, by Application?

Please note: The report will take approximately 2 business days to prepare and deliver.

Table of Contents

159 Pages
*This is a tentative TOC and the final deliverable is subject to change.*
1 Scope of the Report
2 Executive Summary
3 Global by Company
4 World Historic Review for Pregabalin by Geographic Region
5 Americas
6 APAC
7 Europe
8 Middle East & Africa
9 Market Drivers, Challenges and Trends
10 Manufacturing Cost Structure Analysis
11 Marketing, Distributors and Customer
12 World Forecast Review for Pregabalin by Geographic Region
13 Key Players Analysis
14 Research Findings and Conclusion
How Do Licenses Work?
Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.